Brinavess 20 mg (Vernakalant Hydrochloride SOLUTION) 20 MG

BRINAVESS 20 MG is a vernakalant hydrochloride solution for intravenous use, designed for specific cardiac rhythm management. This medication is used to convert recent-onset atrial fibrillation to sinus rhythm.

Strength

20 MG

Pack Size

25ML

Manufacturer / TM Owner

CIPHER PHARMACEUTICALS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BRINAVESS 20 MG is primarily used for the conversion of recent-onset atrial fibrillation to sinus rhythm in adults. It is administered intravenously and is intended for use in clinical settings where continuous electrocardiographic monitoring is available. This medication is not typically used for long-term maintenance of normal heart rhythm but rather for acute episodes of atrial fibrillation.

Side Effects

Common effects of BRINAVESS 20 MG may include changes in heart rate and rhythm, as well as potential sensations of palpitations or discomfort in the chest. Some individuals may experience dizziness or lightheadedness. These effects are generally monitored closely by healthcare professionals during administration.

Precautions & Warnings

BRINAVESS 20 MG should be used with caution in individuals with certain heart conditions or a history of heart disease. It is important to follow the prescribed dosage and administration guidelines provided by a healthcare professional. This medication should only be administered in a setting where continuous electrocardiographic monitoring is available.

Avoid Interactions

BRINAVESS 20 MG may interact with other medications that affect heart rhythm or are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of this medication.

Frequently Asked Questions

BRINAVESS 20 MG is used for the conversion of recent-onset atrial fibrillation to sinus rhythm in adults.

BRINAVESS 20 MG is administered intravenously and should be given in a clinical setting with continuous electrocardiographic monitoring.

Common effects may include changes in heart rate and rhythm, palpitations, and sensations of discomfort in the chest.

Individuals with certain heart conditions or a history of heart disease should use BRINAVESS 20 MG with caution and under medical supervision.

Yes, BRINAVESS 20 MG may interact with other medications that affect heart rhythm or are metabolized by the liver.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.